Gary was co-opted as a trustee in August 2018 and became Chair of the Board on 12 October 2019.
Gary previously had a successful career in the insurance and financial services industry, working in senior roles within well-known British and international companies. Gary stepped down from his role as CEO Europe, Middle East and Africa for Zurich Insurance in October 2018.
Gary is a keen sportsman and played non-league football for many years. Since then he's combined sport and community engagement to raise funds and awareness for both local and national charities. Over the past few years he's thrown himself into wing walking and abseiling, as well as running numerous marathons.
As Chairman of the Zurich's Community Trust he's engaged with companies, governments, charities and academic bodies to help tackle the growing impact of floods globally through early warning and prevention. He's also helped with highlighting the importance of wellbeing, particularly in a digitally enabled world, as well as with finding ways to increase inclusion at work.
Gary was diagnosed with Parkinson's in 2015. He's passionate about exercise, which he finds helps to limit the impact of the condition. He decided to step down from his role in Zurich to better balance work and non-executive roles, with spending more time on fitness and with family. He's also able to use his voice and experience to support increased awareness and action for people living with Parkinson's, their families and carers.
Gary is married with 3 children.
Find out more from our chair, Gary
In his latest news piece, Gary covers how the Board have started doing a few things differently, 'The People Committee', and his Guiness World Record attempt.
Matthew was co-opted and then later appointed to the Board in 2018. Matthew was elected Vice Chair of the Board in November 2019.
Part of the team that created the Catapult programme, Matthew Durdy is also an executive director of the Cell and Gene Therapy Catapult. Matthew is responsible for finding, funding and transacting the business of the Catapult as well as the development of the overall strategy.
He has been a champion of the early integration of healthcare economics and reimbursement expertise into decision-making and clinical product design in the sector.
He began his career in international investment banking and has successfully managed a number of biotechnology SMEs. His first degree was from Oxford University in Biology and he has an MBA (High Honors) from the University of Chicago Booth School of Business.
He is a non-executive director of an immuno-oncology company and periodically assists the government and international organisations in the development of initiatives in healthcare innovation.
Kyle Alexander was appointed by co-option to the Board of Trustees in August 2018, bringing a Northern Ireland presence to the board.
As an urban planner, Kyle has been chief executive and accounting officer of high profile public development corporations in Northern Ireland and brings experience in governance, business planning and project delivery.
Kyle received an OBE in 2007 for services to regeneration in Northern Ireland, having overseen the transformation of Belfast's waterfront by Laganside Corporation. Having successfully managed the winding up of that organisation, he then led the establishment of the Maze Long Kesh Development Corporation, overseeing the regeneration of this politically sensitive site.
Throughout his career he has been committed to both 'people and place', engaging with local communities to ensure delivery of social outcomes. In recognition of his contribution he accepted the invitation to be a Fellow of the Royal Institute of Chartered Surveyors in 2015.
Kyle is a Belfast Harbour Commissioner with a particular interest in corporate social responsibility, a trustee of the community-led Connswater Community Greenway Trust in East Belfast and a trustee of The Waterways Community.
He was previously involved in international networks as a board member of the global urban development association INTA and a member of the European CABERNET brownfield regeneration network.
He is a trustee and elder of a local church and currently editor of the church magazine. Married and living in Lisburn, his interests include gardening, supporting Manchester United and playing with 2 young grandchildren.
Kyle was diagnosed with Parkinson's in 2016 and welcomes the opportunity to help make a difference for other people living with the condition.
Professor David Burn took up the position of Pro-Vice-Chancellor of the Faculty of Medical Sciences at Newcastle University on 1 February 2017.
The Faculty delivers impact through excellence in, and close integration of, research, teaching and engagement across 7 research institutes and 4 teaching schools.
David is also Professor of Movement Disorders Neurology and Honorary Consultant Neurologist for Newcastle upon Tyne Hospitals NHS Foundation Trust.
After finishing his first degree at Oxford (Physiological Sciences), he returned to his native North East for clinical training and early medical jobs, including in neurology.
After further neurology training and undertaking research in London (at the National Hospital for Neurology and Neurosurgery, Queen Square and Hammersmith Hospital) he was appointed as a Consultant Neurologist and Senior Lecturer in Newcastle in 1994.
David has an international reputation for research in dementia associated with Parkinson's. He is an NIHR Senior Investigator and chairs the NIHR Translational Research Collaboration for Dementia.
He served on the Parkinson's UK Research Advisory Panel between 2006 and 2012. As National Clinical Director for the Parkinson's UK Excellence Network between 2014 and 2017, David worked with the Chief Executive and senior charity staff to devise and establish the network, drive innovation, and ensure delivery against key performance indicators.
Beyond this role, David felt highly motivated to retain his connection with Parkinson's UK and to continue to contribute towards delivering the charity's ambitious strategy.
Andrew Cavey was co-opted to the Board of Trustees in August 2018.
He works at Novartis, where he heads the company's clinical development efforts in benign haematology. His role is to help more patients gain access to new and innovative medicines for conditions such as sickle cell disease.
Andrew has spent his career in healthcare globally. He worked as a physician for the NHS in the UK and for a variety of non-governmental organisations in conflict and disaster settings in sub-Saharan Africa and Asia.
He subsequently became a management consultant at McKinsey & Company, focusing on the pharmaceutical sector, before joining Novartis in various senior strategy and commercial roles in Switzerland and China.
He holds medical and physiology degrees from Oxford University and a Masters in Public Health from Harvard. He lives with his wife and 2 sons in Switzerland.
Margaret Chamberlain was elected to the Board of Trustees in September 2013.
Margaret is a solicitor and a senior partner in a City law firm, with experience of dealing with government, large companies and regulators.
She is passionate about making sure that the voices of people affected by Parkinson's are heard by government, the medical profession and in research.
Margaret has supported Parkinson's UK for many years. Her mother had Parkinson's and she also has a close friend with early onset Parkinson's.
Freda Lewis was co-opted to the Board of Trustees in November 2015.
A trained nurse, midwife and health visitor, Freda is a former director of The Fostering Network for Wales and policy manager within the Welsh government. She has extensive experience of the health and social care sectors and the implications of devolution, including legislative differences.
Freda has an MSc in interprofessional studies, researching how professionals work together effectively, completing a dissertation on effective team work in primary care in 2000.
Freda has supported relatives diagnosed with Parkinson's and is keen to give her knowledge and experience to support people affected by the condition.
David graduated from the University of Stirling in 1985 with an Honours degree in German, having spent 2 years during his degree studies working and studying in Switzerland, Germany and Austria. The wanderlust first awoken during his student years was to subsequently lead him to spend the next 28 years in various countries in Asia and the Middle East.
David's Asian sojourn began in Japan, where he spent 6 years teaching English as a foreign language. He then accepted a position lecturing in English at the International Islamic University in Kuala Lumpur.
The next 15 years were to be spent in Malaysia, Singapore and Indonesia and it was during this period that he was to discover his true passion: public relations. His first foray into the world of PR came by way of operations management of Asia's largest chain of modelling agencies, which led to a 4-year stint in event management and concert promotion before joining Malaysia’s largest private tertiary education group as Director of Marketing Communications.
The years 2000–2011 were spent managing multinational PR agencies in Malaysia, Indonesia and the UAE. His work in Indonesia was characterised by being primarily focused on 'social marketing'. An example of this was working with NGOs to encourage behavioural change among mothers and caregivers by educating them on the need for proper post-toilet hygiene in order to reduce the extraordinarily high incidence of infant mortality due to diarrhoea. His firm become the first PR agency in Indonesia to have its work recognised by an international industry body, and a number of the communications programmes he devised were acknowledged as establishing new industry benchmarks and were subsequently rolled out in other South-East Asian markets.
David took early retirement in 2012 following his diagnosis with Parkinson's, having been presenting with symptoms for around 6 years prior to that. He now busies himself with a variety of voluntary roles not only for Parkinson's UK, but also for the Children's Panel and the University of Stirling.
David lives in central Scotland with his partner and their golden Labrador, Angus.
Tim Tamblyn was originally appointed as the interim Trustee from England in September 2014 but was later elected to this role in September 2015.
Tim is a chartered accountant and is a retired partner of the international accounting and consultancy organisation KPMG.
He is an experienced non-executive director and trustee, and has held non-executive positions in the voluntary sector in social housing, education and the NHS.
Tim cares passionately about the vulnerable people in our society and is a trustee and member of 2 national charities that support those with learning disabilities.
Tim was diagnosed with Parkinson's in 2012.
Paresh Thakrar is the Commercial Director of Brit Insurance.
He was previously the COO of HiscoxRe and ILS, based in London, driving strategy, technology and operations for the business, and has been pivotal in bringing product, capital and tech innovation into the corporate DNA.
Paresh began his career trading emerging markets securities at Deutsche Bank, followed by 7 years as a senior diplomat serving the government as a specialist in global security issues.
He then worked at consultants McKinsey & Company where he served a range of investment and retail banks.
Paresh holds a BA/MA from the University of Cambridge and an MBA from the London Business School.
Paul Warner was elected to the Board of Trustees in October 2017.
He has an MBA from Henley Management College and is a graduate of the University of Liverpool.
Paul is a chartered accountant and has worked both in practice and industry, retiring from the position of finance director of an SME subsidiary of an international group.
His experience has been varied, covering both commercial operations as well finance.
He is the treasurer of his local Parkinson's UK branch as well as being a trustee of a pension scheme.
Paul was diagnosed with Parkinson's in 2013 and due to the issues he experienced during diagnosis and treatment he is dedicated to improving the services and support for other people living with Parkinson's.
Peter Miller was elected to the Board of Trustees in October 2019.
Peter retired in 2017 following a career working for large international technology companies and a leading global education business. He has extensive experience in marketing, strategy development and change management.
In a voluntary capacity, Peter is now Chair of an education charity and has considerable experience as a Trustee and Non-Executive Director.
Peter’s journey with Parkinson’s started when his wife was diagnosed in 2014. Since then he has been involved in many aspects of the work of Parkinson’s UK at a local and national level, particularly in research-related activities.
At the start of 2018 Peter co-founded Fighting Fit, a weekend residential programme for active and working-age people with Parkinson’s, delivering a potentially life-changing programme to help participants and their partners live well with the condition.
Peter cares passionately about enhancing public awareness of Parkinson’s, accelerating research outcomes and ensuring the resources of Parkinson’s UK are focused on improving outcomes.
Jane was elected to the Board of Trustees in October 2019.
Jane is Executive Director of the Clean Air Fund, a UK charitable foundation, which she set up in early 2019. Her role setting up and now leading the organisation means she has recently established her own Board and governance processes, is familiar with best practice, and reports directly into the Chair of the Board and Trustees.
Previously, Jane worked as Head of Climate and Energy Science in the UK Government. Prior to working in central government, Jane was Head of Energy and Environment at the National Physical Laboratory, a UK government-owned science and technology laboratory. Jane’s other previous roles include Founder and CEO of an environmental business called Carbon Retirement, and a strategy consultant.
For her work in the charitable and environmental sectors, Jane has been named as a ‘Young Global Leader’ of the World Economic Forum.
Jane’s father was diagnosed with Parkinson’s aged 40. The charity is very close to her heart. Over the last fifteen years, she has completed several marathons and long-distance triathlons to raise sponsorship and taken part in Parkinson’s events.